An in silico approach for modelling t-helper polarizing iNKT cell agonists

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  De Spiegeleer, Anton ^a   Wynendaele, Evelien ^a   Vandekerckhove, Matthias ^a   Stalmans, Sofie ^a   Boucart, Maxime ^a   Van Den Noortgate, Nele ^a   Venken, Koen ^a   Van Calenbergh, Serge ^a   Aspeslagh, Sandrine ^a   Elewaut, Dirk ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CELL POLARITY; COMPARATIVE STUDY; COMPUTER MODEL; CONTROLLED STUDY; HELPER CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER T CELL; NONHUMAN; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; COMPUTER SIMULATION; GALACTOSYLCERAMIDES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR STRUCTURE; NATURAL KILLER T-CELLS; PRINCIPAL COMPONENT ANALYSIS; ROC CURVE; TH1 CELLS; TH2 CELLS;

EID: 84900307794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087000     Document Type: Article

References (30)

1. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nature reviews Immunology 12: 845-857.
2. Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, et al. (2004) Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis and rheumatism 50: 305-313. (Pubitemid 38084316)
3. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L (2012) Targeting natural killer cells and natural killer T cells in cancer. Nature Reviews Immunology 12: 239-252.
4. Drennan MB, Aspeslagh S, Elewaut D (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma. Nat Rev Rheumatol 6: 90-98.
5. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 20: 358-368.
6. Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, et al. (2003) Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. P Natl Acad Sci USA 100: 8395-8400. (Pubitemid 36842556)
7. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ (2008) Innate immunity and aging. Exp Gerontol 43: 718-728.
8. Grubeck-Loebenstein B, Wick G (2002) The aging of the immune system. Adv Immunol 80: 243-284. (Pubitemid 34625625)
9. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5: 133-139. (Pubitemid 38208354)
10. Alberti S, Cevenini E, Ostan R, Capri M, Salvioli S, et al. (2006) Age-dependent modifications of Type 1 and Type 2 cytokines within virgin, and memory CD4(+) T cells in humans. Mech Ageing Dev 127: 560-566.
11. Baruch K, Ron-Harel N, Gal H, Deczkowska A, Shifrut E, et al. (2013) CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. P Natl Acad Sci USA 110: 2264-2269.
12. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstrom C, Wold S (2006) Multi- and Megavariate Data Analysis: Part I - Basic Principles and Applications. Umetrics Academy.
13. Van Dorpe S, Vergote V, Pezeshki A, Burvenich C, Peremans K, et al. (2010) Hydrophilic interaction LC of peptides: Columns comparison and clustering. J Sep Sci 33: 728-739.
14. Derringer G, Suich R (1980) Simultaneous-Optimization of Several Response Variables. J Qual Technol 12: 214-219.
15. Derringer GC (1994) A Balancing Act - Optimizing a Products Properties. Qual Prog 27: 51-58.
16. Van Dorpe S, Adriaens A, Vermeire S, Polis I, Peremans K, et al. (2011) Desirability function combining metabolic stability and functionality of peptides. J Pept Sci 17: 398-404.
17. Wold S, Sjostrom M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab 58: 109-130. (Pubitemid 33033283)
18. Yu ED, Girardi E,Wang J, Zajonc DM (2011) Cutting Edge: Structural Basis for the Recognition of beta-Linked Glycolipid Antigens by Invariant NKT Cells. J Immunol 187: 2079-2083.
19. Sullivan BA, Nagarajan NA, Wingender G, Wang J, Scott I, et al. (2010) Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V alpha 14i NKT Cells. J Immunol 184: 141-153.
20. Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, et al. (2002) Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha- galactosylceramide. Blood 99: 1259-1266. (Pubitemid 34547079)
21. Bai L, Constantinides MG, Thomas SY, Reboulet R, Meng FY, et al. (2012) Distinct APCs Explain the Cytokine Bias of alpha-Galactosylceramide Variants In Vivo. J Immunol 188: 3053-3061.
22. Oki S, Chiba A, Yamamura T, Miyake S (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113: 1631-1640. (Pubitemid 39071687)
23. Berkers CR, Ovaa H (2005) Immunotherapeutic potential for ceramide-based activators of iNKT cells. Trends Pharmacol Sci 26: 252-257. (Pubitemid 40603073)
24. Im JS, Arora P, Bricard G, Molano A, Venkataswamy MM, et al. (2009) Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation. Immunity 30: 888-898.
25. Bai L, Sagiv Y, Liu Y, Freigang S, Yu KOA, et al. (2009) Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alpha GalCer. P Natl Acad Sci USA 106: 10254-10259.
26. Aspeslagh S, Li YL, Yu ED, Pauwels N, Trappeniers M, et al. (2011) Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. Embo J 30: 2294-2305.
27. Aspeslagh S, Nemcovic M, Pauwels N, Venken K, Wang J, et al. (2013) Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection. J Immunol 191: 2916-2925.
28. Wu TN, Lin KH, Chang YJ, Huang JR, Cheng JY, et al. (2011) Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy. P Natl Acad Sci USA 108: 17275-17280.
29. Schiefner A, Fujio M, Wu D, Wong CH, Wilson IA (2009) Structural Evaluation of Potent NKT Cell Agonists: Implications for Design of Novel Stimulatory Ligands. J Mol Biol 394: 71-82.
30. Jervis PJ, Graham LM, Foster EL, Cox LR, Porcelli SA, et al. (2012) New CD1d agonists: Synthesis and biological activity of 6 ″-triazole- substituted alpha-galactosyl cramides. Bioorg Med Chem Lett 22: 4348-4352.